October 2, 2025Current Pharmaceutical Biotechnology

Evaluating the Protective Immunity of 5’-Cap Altered Rabies mRNA Vaccines in a Mouse Model

View Full Paper

Ask AI

Bookmark

Authors

TZTeng ZhangXinjiang Agricultural University WZWen Zhang

Discussion

Member takes

Implication

Assessment reveals the efficacy of 5'-cap mRNA vaccines in enhancing protective immunity against rabies, indicating potential for clinical applications.

Key Points

The modified 5'-cap mRNA vaccine effectively reduced rabies viral load in mice, enhancing survival rates.
Antibody detection indicated a strong immunogenic response generated by the three vaccine variants.
ELISPOT assays showed increased production of immune-related cytokines in response to the mRNA vaccines.
These findings suggest that modified mRNA vaccines could serve as valuable candidates for rabies prevention.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68de68e583cbc991d0a211fc https://doi.org/10.2174/0113892010396404250903044326

View Full Paper

Ask AI

Bookmark

Implication

Assessment reveals the efficacy of 5'-cap mRNA vaccines in enhancing protective immunity against rabies, indicating potential for clinical applications.

Evaluating the Protective Immunity of 5’-Cap Altered Rabies mRNA Vaccines in a Mouse Model

Discussion

Member takes

Implication

Key Points

Cite This Study

Evaluating the Protective Immunity of 5’-Cap Altered Rabies mRNA Vaccines in a Mouse Model

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider